Phase II trial of acivicin in malignant mesothelioma

Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth.

Oncogene·2012

G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer.

Oncogene·2011

Potentiation of apoptosis by histone deacetylase inhibitors and doxorubicin combination: cytoplasmic cathepsin B as a mediator of apoptosis in multiple myeloma.

British journal of cancer·2011

Phase II study of pegylated liposomal doxorubicin and carboplatin in patients with platinum-sensitive and partially platinum-sensitive metastatic ovarian cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2009

A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen.

Cancer chemotherapy and pharmacology·2009

Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.

Cancer treatment reports·1987

IV melphalan in children.

Cancer treatment reports·1987

Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.

Cancer treatment reports·1987

Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.

Cancer treatment reports·1987

Doxorubicin distribution in human breast cancer.

Cancer treatment reports·1987

Phase I study of echinomycin.

Cancer treatment reports·1987

Immune Cell Engager Therapy for Brain Cancer.

Neuro-oncology·2026

Gut microbiota-mediated dietary lignans metabolism drives accumulation of N,N-dimethylsphingosine and sensitizes triple-negative breast cancer to paclitaxel.

Food & function·2026

Ocular Microcystic Adnexal Carcinoma With High-Grade Features: A Case Report With Orbital Exenteration.

International journal of surgical pathology·2026

Effect of photobiomodulation therapy on regulating reparative processes of chronic wounds at the inflammation stage.

Biomedica : revista del Instituto Nacional de Salud·2026

Doxorubicin and 4-Hydroperoxycyclophosphamide Alter Mitochondrial Dynamics and miR-34 Expression in Spermatogonia and Spermatocytes In Vitro.

Basic & clinical pharmacology & toxicology·2026

Neurotoxicity and cognitive outcomes in modern therapies for primary central nervous system lymphoma.

Current opinion in oncology·2026

Related Experiment Videos

Phase II trial of acivicin in malignant mesothelioma

Related Concept Videos

Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684.

A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth.

G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer.

Potentiation of apoptosis by histone deacetylase inhibitors and doxorubicin combination: cytoplasmic cathepsin B as a mediator of apoptosis in multiple myeloma.

Phase II study of pegylated liposomal doxorubicin and carboplatin in patients with platinum-sensitive and partially platinum-sensitive metastatic ovarian cancer.

A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen.

Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.

IV melphalan in children.

Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.

Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.

Doxorubicin distribution in human breast cancer.

Phase I study of echinomycin.

Immune Cell Engager Therapy for Brain Cancer.

Gut microbiota-mediated dietary lignans metabolism drives accumulation of N,N-dimethylsphingosine and sensitizes triple-negative breast cancer to paclitaxel.

Ocular Microcystic Adnexal Carcinoma With High-Grade Features: A Case Report With Orbital Exenteration.

Effect of photobiomodulation therapy on regulating reparative processes of chronic wounds at the inflammation stage.

Doxorubicin and 4-Hydroperoxycyclophosphamide Alter Mitochondrial Dynamics and miR-34 Expression in Spermatogonia and Spermatocytes In Vitro.

Neurotoxicity and cognitive outcomes in modern therapies for primary central nervous system lymphoma.

Related Experiment Videos

Phase II trial of acivicin in malignant mesothelioma

Related Concept Videos

Related Articles